拓邦股份(002139.SZ)及控股子公司擬向銀行申請累計不高於78億元綜合授信額度
格隆匯 3 月 8日丨拓邦股份(002139.SZ)公佈,公司2020年度的銀行綜合授信額度陸續到期,且公司業務發展較快,為了滿足公司日常生產經營的資金需求,公司及其控股子公司擬向銀行申請累計不高於人民幣(含)78億元的綜合授信額度。授信品類包括但不限於公司日常生產經營的長、短期貸款、銀行承兑匯票、貿易融資、保函、信用證、外匯衍生產品等。
各銀行授信額度有效期為一年,具體綜合授信額度、授信品類及其他條款以公司與各銀行最終簽訂的協議為準,授信額度在總額度範圍內可以在不同銀行間進行調整,公司及公司控股的子公司皆可以使用此次申請的綜合授信額度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.